VTE is a relatively common event, with a lifetime prevalence of approximately 1 in 20 people. Decisions about who to treat, with which drug, at what dose and for what duration can be complex. NPS Medicinewise have recently provided excellent guidance. Salient messages...
A recent systematic review and meta-analysis has examined the effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on dialysis, transplantation and death due to kidney disease in patients with type 2 diabetes. The reliability of effect size across trials was...
Earlier this year, the World Health Organization endorsed 17 September as the day that will be observed annually as World Patient Safety Day. The theme for the event in 2019 will be: Patient Safety: a global health priority, and the slogan will be: Speak up for...
The Veterans Mates service, provided by the Australian Department of Veterans Affairs, develops and distributes excellent resources that can be accessed by health care professionals and consumers to support quality use of medicines. The latest topic addressed relates...
The incidence of opioid prescribing and associated overdose deaths in the United States has been increasing since 1999, with the initial introduction of opioids to patients in emergency departments (EDs) appearing to playing a key role in the resultant opioid...
